522 related articles for article (PubMed ID: 16458191)
1. Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans.
Covas MI; de la Torre K; Farré-Albaladejo M; Kaikkonen J; Fitó M; López-Sabater C; Pujadas-Bastardes MA; Joglar J; Weinbrenner T; Lamuela-Raventós RM; de la Torre R
Free Radic Biol Med; 2006 Feb; 40(4):608-16. PubMed ID: 16458191
[TBL] [Abstract][Full Text] [Related]
2. Effects of differing phenolic content in dietary olive oils on lipids and LDL oxidation--a randomized controlled trial.
Marrugat J; Covas MI; Fitó M; Schröder H; Miró-Casas E; Gimeno E; López-Sabater MC; de la Torre R; Farré M;
Eur J Nutr; 2004 Jun; 43(3):140-7. PubMed ID: 15168036
[TBL] [Abstract][Full Text] [Related]
3. Evidence of postprandial absorption of olive oil phenols in humans.
Bonanome A; Pagnan A; Caruso D; Toia A; Xamin A; Fedeli E; Berra B; Zamburlini A; Ursini F; Galli G
Nutr Metab Cardiovasc Dis; 2000 Jun; 10(3):111-20. PubMed ID: 11006919
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability of phenolic compounds from olive oil and oxidative/antioxidant status at postprandial state in healthy humans.
Weinbrenner T; Fitó M; Farré Albaladejo M; Saez GT; Rijken P; Tormos C; Coolen S; De La Torre R; Covas MI
Drugs Exp Clin Res; 2004; 30(5-6):207-12. PubMed ID: 15700748
[TBL] [Abstract][Full Text] [Related]
5. Changes in the phenolic content of low density lipoprotein after olive oil consumption in men. A randomized crossover controlled trial.
Gimeno E; de la Torre-Carbot K; Lamuela-Raventós RM; Castellote AI; Fitó M; de la Torre R; Covas MI; López-Sabater MC
Br J Nutr; 2007 Dec; 98(6):1243-50. PubMed ID: 17617938
[TBL] [Abstract][Full Text] [Related]
6. Tyrosol and hydroxytyrosol are absorbed from moderate and sustained doses of virgin olive oil in humans.
Miró-Casas E; Covas MI; Fitó M; Farré-Albadalejo M; Marrugat J; de la Torre R
Eur J Clin Nutr; 2003 Jan; 57(1):186-90. PubMed ID: 12548315
[TBL] [Abstract][Full Text] [Related]
7. New insights into controversies on the antioxidant potential of the olive oil antioxidant hydroxytyrosol.
Rietjens SJ; Bast A; Haenen GR
J Agric Food Chem; 2007 Sep; 55(18):7609-14. PubMed ID: 17683140
[TBL] [Abstract][Full Text] [Related]
8. Virgin olive oil phenolic compounds: binding to human low density lipoprotein (LDL) and effect on LDL oxidation.
Covas MI; Fitó M; Lamuela-Raventós RM; Sebastiá N; de la Torre-Boronat C; Marrugat J
Int J Clin Pharmacol Res; 2000; 20(3-4):49-54. PubMed ID: 11314237
[TBL] [Abstract][Full Text] [Related]
9. Effect of ingestion of virgin olive oil on human low-density lipoprotein composition.
Gimeno E; Fitó M; Lamuela-Raventós RM; Castellote AI; Covas M; Farré M; de La Torre-Boronat MC; López-Sabater MC
Eur J Clin Nutr; 2002 Feb; 56(2):114-20. PubMed ID: 11857044
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability of tyrosol, an antioxidant phenolic compound present in wine and olive oil, in humans.
Covas MI; Miró-Casas E; Fitó M; Farré-Albadalejo M; Gimeno E; Marrugat J; De La Torre R
Drugs Exp Clin Res; 2003; 29(5-6):203-6. PubMed ID: 15134375
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability and antioxidant effects of olive oil phenols in humans: a review.
Vissers MN; Zock PL; Katan MB
Eur J Clin Nutr; 2004 Jun; 58(6):955-65. PubMed ID: 15164117
[TBL] [Abstract][Full Text] [Related]
12. Effect of virgin olive oil phenolic compounds on in vitro oxidation of human low density lipoproteins.
Caruso D; Berra B; Giavarini F; Cortesi N; Fedeli E; Galli G
Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):102-7. PubMed ID: 10464782
[TBL] [Abstract][Full Text] [Related]
13. Capillary gas chromatography-mass spectrometry quantitative determination of hydroxytyrosol and tyrosol in human urine after olive oil intake.
Miró-Casas E; Farré Albaladejo M; Covas MI; Rodriguez JO; Menoyo Colomer E; Lamuela Raventós RM; de la Torre R
Anal Biochem; 2001 Jul; 294(1):63-72. PubMed ID: 11412007
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability and antioxidant effects of olive oil phenolic compounds in humans: a review.
Fitó M; de la Torre R; Farré-Albaladejo M; Khymenetz O; Marrugat J; Covas MI
Ann Ist Super Sanita; 2007; 43(4):375-81. PubMed ID: 18209271
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant activities of hydroxytyrosol main metabolites do not contribute to beneficial health effects after olive oil ingestion.
Khymenets O; Fitó M; Touriño S; Muñoz-Aguayo D; Pujadas M; Torres JL; Joglar J; Farré M; Covas MI; de la Torre R
Drug Metab Dispos; 2010 Sep; 38(9):1417-21. PubMed ID: 20516254
[TBL] [Abstract][Full Text] [Related]
16. Tyrosol, the major extra virgin olive oil compound, restored intracellular antioxidant defences in spite of its weak antioxidative effectiveness.
Di Benedetto R; Varì R; Scazzocchio B; Filesi C; Santangelo C; Giovannini C; Matarrese P; D'Archivio M; Masella R
Nutr Metab Cardiovasc Dis; 2007 Sep; 17(7):535-45. PubMed ID: 16928436
[TBL] [Abstract][Full Text] [Related]
17. Bioactive effects of olive oil phenolic compounds in humans: reduction of heart disease factors and oxidative damage.
Covas MI
Inflammopharmacology; 2008 Oct; 16(5):216-8. PubMed ID: 18815741
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant effect of two virgin olive oils depends on the concentration and composition of minor polar compounds.
Franconi F; Coinu R; Carta S; Urgeghe PP; Ieri F; Mulinacci N; Romani A
J Agric Food Chem; 2006 Apr; 54(8):3121-5. PubMed ID: 16608240
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of action of phenolic compounds in olive.
Rafehi H; Ververis K; Karagiannis TC
J Diet Suppl; 2012 Jun; 9(2):96-109. PubMed ID: 22607645
[TBL] [Abstract][Full Text] [Related]
20. [Coronary disease protective factors: antioxidant effect of olive oil].
Covas MI; Fitó M; Marrugat J; Miró E; Farré M; de la Torre R; Gimeno E; López-Sabater MC; Lamuela-Raventós R; de la Torre-Boronat MC
Therapie; 2001; 56(5):607-11. PubMed ID: 11806301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
